STOCK TITAN
  1. Home
  2. Sec-filings
  3. CGEN
  4. [Form 4] COMPUGEN LTD Insider Trading Activity

Compugen (CGEN) grants director options and RSUs with long vesting

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Compugen director Eran Perry reported two equity awards dated 2026-07-29: a grant of 10,000 share options to buy ordinary shares at an exercise price of $2.2600 expiring 2036-07-29, and an award of 7,500 restricted stock units. Both grants vest 25% on October 1, 2027, with the balance vesting in 12 equal quarterly installments, subject to continued service. Following these awards, Perry directly holds 17,500 ordinary shares and options for 10,000 shares.

Positive

  • None.

Negative

  • None.
Insider Perry Eran
Role Director
Type Security Shares Price Value
Grant/Award Share Option (right to buy) F2 10,000 $0.00 $0.00
Grant/Award Ordinary Shares F1 7,500 $0.00 $0.00
Holdings After Transaction: Share Option (right to buy) — 10,000 shares (Direct); Ordinary Shares — 17,500 shares (Direct)
Footnotes (2)
  1. F1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
  2. F2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
Share options granted 10000.0000 shares Share Option (right to buy) grant to Eran Perry on 2026-07-29
RSUs granted 7500.0000 shares Restricted stock unit award to Eran Perry on 2026-07-29
Option exercise price 2.2600 per share Exercise price of share options granted 2026-07-29
Option expiration date 2036-07-29 Expiration date of the 10,000 share options granted to Eran Perry
Ordinary shares held after grant 17500.0000 shares Direct ordinary share holdings of Eran Perry after RSU award
restricted stock unit ("RSU") financial
"Represents a restricted stock unit ("RSU") award."
Share Option (right to buy) financial
"Security title is Share Option (right to buy)."
vests 25% financial
"The RSUs vest 25% on October 1, 2027."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What insider transactions did Compugen (CGEN) report for director Eran Perry?
Compugen reported that director Eran Perry received two equity awards dated 2026-07-29: 10,000 share options to buy ordinary shares at an exercise price of $2.2600 and 7,500 restricted stock units, both subject to multi-year vesting based on continued service.

How many RSUs were granted to Compugen (CGEN) director Eran Perry?
Eran Perry was granted 7,500 restricted stock units (RSUs). The RSUs vest 25% on October 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments thereafter, conditioned on Perry’s continued service to Compugen.

What are the vesting terms of Eran Perry’s new Compugen (CGEN) equity awards?
Both the 7,500 RSUs and 10,000 share options vest on the same schedule: 25% on October 1, 2027, with the remaining portion vesting in 12 equal quarterly installments, subject to Eran Perry’s continued service to the company.

What is the exercise price and expiration date of Eran Perry’s Compugen (CGEN) options?
The share options granted to Eran Perry cover 10,000 ordinary shares at an exercise price of $2.2600 per share and expire on 2036-07-29. These options vest gradually beginning October 1, 2027, contingent on continued service.

How many Compugen (CGEN) shares does Eran Perry hold after these grants?
After the reported grants, Eran Perry directly holds 17,500 ordinary shares and options for 10,000 shares. The 17,500 shares include the impact of the new 7,500 RSUs, which will settle into shares as they vest over time.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Perry Eran
(Last)(First)(Middle)
C/O COMPUGEN LTD.
26 HAROKMIM STREET
(Street)
HOLON5885849
(City)(State)(Zip)
ISRAEL
(Country)		2. Issuer Name and Ticker or Trading Symbol
COMPUGEN LTD [ CGEN ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
[CGEN]
3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Ordinary Shares07/29/2026A7,500(1)A$017,500D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Share Option (right to buy)$2.2607/29/2026A10,000 (2)07/29/2036Ordinary Shares10,000$010,000D
Explanation of Responses:
1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
/s/ Eran Perry07/30/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR